Researchers Find New Molecule to Aid Cystic Fibrosis Treatment
Cystic fibrosis is a disease that causes damage to the lungs and digestive system. The disease causes a cycle of respiratory inflammation and infection which deteriorates the lungs. Cystic fibrosis has no known cure, and current treatments are limited to easing symptoms and prolonging life.
Researchers at Queen’s University Belfast in the United Kingdom are now looking at a new molecule to improve quality of life and prolong life expectancy.
This molecule inhibits channel-activating enzymes on the surface of epithelial cells, which reduced sodium channel activity. This can allow better airway hydration and clearance of mucus. Mucus that accumulates on the lining of the airways can trap bacteria, leading to infection, inflammation, and more. Allowing better clearance of this mucus in CF patients can improve symptoms. Researchers are now looking at using the molecule as a potential treatment to delay or prevent cystic fibrosis-related lung disease.
The World Health Organization estimates 100,000 people worldwide are living with cystic fibrosis. Mortality rates are high, but advances in treatments allow many cystic fibrosis patients to live past their 30s.
Cystic Fibrosis is a Disability That May Qualify for Benefits
Cystic fibrosis is a genetic condition typically diagnosed in the childhood years. If your child meets the Social Security disability criteria, he or she may be qualified to receive disability benefits. If you are an adult with cystic fibrosis and can no longer work due to your condition, you may also qualify for benefits.
Call the Disability Help Group at 800-800-2009 or contact us online to schedule a consultation with our disability advocates.